Haemonetics Corp
NYSE:HAE

Watchlist Manager
Haemonetics Corp Logo
Haemonetics Corp
NYSE:HAE
Watchlist
Price: 83 USD 0.28% Market Closed
Market Cap: 3.9B USD

Wall Street
Price Targets

HAE Price Targets Summary
Haemonetics Corp

Wall Street analysts forecast HAE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HAE is 93.53 USD with a low forecast of 74.74 USD and a high forecast of 113.4 USD.

Lowest
Price Target
74.74 USD
10% Downside
Average
Price Target
93.53 USD
13% Upside
Highest
Price Target
113.4 USD
37% Upside
Haemonetics Corp Competitors:
Price Targets
STAA
STAAR Surgical Co
16% Upside
GENT
Gentian Diagnostics ASA
19% Upside
MED
Medartis Holding AG
2% Upside
LAXMIDENTL
Laxmi Dental Ltd
65% Upside
1501
Shanghai Kindly Medical Instruments Co Ltd
15% Upside
688016
Shanghai MicroPort Endovascular MedTech Group Co Ltd
37% Upside
FIGS
Figs Inc
19% Downside
CTEC
ConvaTec Group PLC
30% Upside

Revenue
Forecast

Revenue Estimate
Haemonetics Corp

For the last 13 years the compound annual growth rate for Haemonetics Corp's revenue is 5%. The projected CAGR for the next 3 years is 4%.

5%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Haemonetics Corp

For the last 13 years the compound annual growth rate for Haemonetics Corp's operating income is 7%. The projected CAGR for the next 3 years is 20%.

7%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Net Income
Forecast

Net Income Estimate
Haemonetics Corp

For the last 13 years the compound annual growth rate for Haemonetics Corp's net income is 7%. The projected CAGR for the next 3 years is 20%.

7%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-49%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HAE's stock price target?
Price Target
93.53 USD

According to Wall Street analysts, the average 1-year price target for HAE is 93.53 USD with a low forecast of 74.74 USD and a high forecast of 113.4 USD.

What is Haemonetics Corp's Revenue forecast?
Projected CAGR
4%

For the last 13 years the compound annual growth rate for Haemonetics Corp's revenue is 5%. The projected CAGR for the next 3 years is 4%.

What is Haemonetics Corp's Operating Income forecast?
Projected CAGR
20%

For the last 13 years the compound annual growth rate for Haemonetics Corp's operating income is 7%. The projected CAGR for the next 3 years is 20%.

What is Haemonetics Corp's Net Income forecast?
Projected CAGR
20%

For the last 13 years the compound annual growth rate for Haemonetics Corp's net income is 7%. The projected CAGR for the next 3 years is 20%.

Back to Top